Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion type Assertion NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_head.
- NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion description "[The aggregate frequency of CHD5 haploinsufficiency or inactivation is 16.2% in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_provenance.
- NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion evidence source_evidence_literature NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_provenance.
- NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion SIO_000772 18953434 NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_provenance.
- NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion wasDerivedFrom befree-20140225 NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_provenance.
- NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_assertion wasGeneratedBy ECO_0000203 NP581338.RA4EFNhJxEw5Mcr0sDAgn8msjwzpKyXp1bLywmEbRgaHE130_provenance.